Patheon stock falls as Puerto Rico subsidiary gets warning letter from FDA

TORONTO (CP) - Patheon Inc. stock sagged to a 5 1/2-year low Monday after a recently acquired subsidiary in Puerto Rico received a warning letter from the U.S. Food and Drug Administration. The Canadian contract drug manufacturer's shares (TSX:PTI) closed down 6....More